Skip to content

KATMED

Active Private limited companyfounded 2021active for 4 yearsA. De Boecklaan 36, 1780 WemmelKBO/BCE: BE 0779.493.483

Lifetime

4 annual accounts with figures on one time axis
peak of €109,391 in 2022
€85,505▲ 45.5%
peak of €79,171 in 2022
€15,998▼ 59.9%
peak of €205,938 in 2025
€205,938▲ 7.9%
€6,276▼ 52.6%
peak of 0.3 FTE in 2022
-not published
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
05-06-202656 days before the deadline
2025micro format
Gross margin from €58,779 to €85,505Result from €39,868 to €15,998Dividend €833Debts from €13,241 to €6,276Investments €18,914

Key points

from the 2025 annual accounts

Investments

€18,914 2.4 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Liquidity

42.56 was 14.52 in 2024

Short-term debts fell from €13,241 to €5,525.

Filings

4 annual accounts 2 late
AprilJune31 JulyOctober2022202320242025

The 2023 accounts came in latest, 51 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,328 companies had the same profile as KATMED has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,328 companies, not a prediction for KATMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-12-2021
Director, since 01-01-2024
  • founderdeed of 31-12-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0779493483
appointed as director acts as permanent representative · Gazette deed
New establishment in Brussels MediNOH, Ijzerkruisenlaan 11
Incorporation Founded by · 1,000 shares · appointed as director · published on 31-12-2021 · Gazette deed
All 13 events

Comparable companies

same main activity, similar in size and age
Company
KATMED Wemmel €257,967 €85,505 79.8% -
MEDIVIC Molenbeek-Saint-Jean €251,347 €88,639 73.9% -
Dr. Natalia Bautista Vera Antwerp €248,364 €79,801 39.3% -
Dr Héloïse Bourbier Schaerbeek €263,331 €81,073 35.4% -
Dr. Thomas Verdonck Antwerp €241,536 €93,660 91.8% 0
OPHTASENS Sint-Gillis (bij-Brussel) €293,275 €82,831 71.5% -
ODENTS Koekelberg €249,959 €77,999 28.1% -

These companies have the same main activity as KATMED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €242,000 and €293,000, founded between 2021 and 2022.

Official details

Source: KBO
Status
Active since 29-12-2021Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.327.998.0201780 Wemmel, since 29-12-2021
2.332.873.0611120 Brussels, since 23-05-2022
Financial year end
31 December
Peppol
Reachable since 10-12-2025
Company details

Annual accounts 2025

≈ €190,000estimated
€257,967▲ 26.4%
Filing
Filed on 05-06-2026, 56 days before the end of the filing period
Financials

Insights on KATMED

KATMED files the micro format. That format states no turnover. The gross margin fell from €109,391 in 2022 to €85,505 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about KATMED

What is the company number of KATMED?
The company number of KATMED is 0779.493.483. The VAT number is the same number with BE in front: BE 0779.493.483.
Where is KATMED based?
The registered office is at A. De Boecklaan 36, 1780 Wemmel.Company details
What does KATMED do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of KATMED?
KATMED is a private limited company (BV).
When was KATMED founded?
KATMED was founded on 29-12-2021.
Is KATMED still active?
Yes, KATMED is an active enterprise in the KBO register.
How many employees does KATMED have?
KATMED had an average of 0.3 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of KATMED?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €85,505 and 33 comparable companies (NACE 862). It probably lies between €140,000 and €240,000.
Is KATMED profitable?
In financial year 2025, KATMED made a profit of €15,998.
Where can I find the annual accounts of KATMED?
KATMED filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KATMED due?
KATMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.